Streptococcus Group B anticorps (HRP)

N° du produit ABIN112835

Détail du produit anti-Streptococcus Group B anticorps (HRP)

Antigène: Streptococcus Group B

Reactivité: Streptococcus

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Streptococcus Group B est conjugé à/à la HRP

Application: Enzyme Immunoassay (EIA)

Purification: Immunoaffinity chromatography.

Immunogène: Streptococci, group B

Information d'application

Indications d'application: Suitable for use in ELISA.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1.0 mg/mL (OD280 nm, E0.1% = 1.4)

Buffer: PBS containing 10 mg/mL BSA as stabilizer and 0.002 % Thimerosal as preservative.

Agent conservateur: Thimerosal (Merthiolate)

Précaution d'utilisation: This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur Streptococcus Group B

Antigène: Streptococcus Group B

Abstract: Streptococcus Group B Produits

Classe de substances: Bacteria

Sujet: Streptococci form part of the normal human flora that resides on the skin, and can also colonise the respiratory, gastrointestinal, and genitourinary tracts. Streptococci can cause a range of diseases, from the less serious but common sore throats and skin infections to life threatening conditions such as necrotising fasciitis. Different streptococcal species are involved in human disease, broadly categorised as pus forming or pyogenic streptococci, non pus forming or non pyogenic streptococci, and Streptococcus pneumoniae. Streptococci are classified into Lancefield serotypes by their cell wall polysaccharide antigens. Group A are primarily pathogens. Group B streptococci (including Streptococcus agalactiae) are the leading bacterial causes of human neonatal illness and death causing opportunistic invasive disease in pregnant women such as preterm labour, membrane rupture and urinary tract infections and sepsis and meningitis in newborns.